PRC Clinical Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • PRC Clinical's estimated annual revenue is currently $9.4M per year.(i)
  • PRC Clinical's estimated revenue per employee is $201,000

Employee Data

  • PRC Clinical has 47 Employees.(i)
  • PRC Clinical grew their employee count by 12% last year.

PRC Clinical's People

NameTitleEmail/Phone
1
Co-founder, Partner & ConsultantReveal Email/Phone
2
Manager, Clinical ProjectsReveal Email/Phone
3
President, COOReveal Email/Phone
4
Executive Assistant / Administrative AssistantReveal Email/Phone
5
Clinical Research AssociateReveal Email/Phone
6
Clinical Trial AssistantReveal Email/Phone
7
Clinical Research AssociateReveal Email/Phone
8
Executive Assistant / Administrative AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is PRC Clinical?

PRC Clinical has provided specialty CRO services to biotech and pharmaceutical companies for more than 15 years. Our innovative approach to executing studies combines high-touch human elements and cutting-edge technology with extensive experience and deep therapeutic knowledge. We believe that highly specialized early-phase trials deserve high-touch approaches to ensure high-quality results. At PRC, we go the extra mile to account for every aspect of your project, so you can rest assured that your trial is being handled with the utmost care. When you need special handling for your specialized research, get TLC from PRC.

keywords:N/A

N/A

Total Funding

47

Number of Employees

$9.4M

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.2M47-6%N/A
#2
$7.7M47-24%N/A
#3
$5.6M48N/AN/A
#4
$3.5M49-2%N/A
#5
$5.7M497%N/A